Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft vs Host Disease | Preclinical | CN | 10 Nov 2022 | |
Graft vs Host Disease | Preclinical | CN | 10 Nov 2022 |